APA (7th ed.) Citation

J, C., MC, L., LE, L., M, G., LB, S., AD, F., . . . TR, C. (2017). Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer. Oncotarget, 8(16), 26066. https://doi.org/10.18632/oncotarget.15257

Chicago Style (17th ed.) Citation

J, Chang, et al. "Pre-clinical Evaluation of Small Molecule LOXL2 Inhibitors in Breast Cancer." Oncotarget 8, no. 16 (2017): 26066. https://doi.org/10.18632/oncotarget.15257.

MLA (9th ed.) Citation

J, Chang, et al. "Pre-clinical Evaluation of Small Molecule LOXL2 Inhibitors in Breast Cancer." Oncotarget, vol. 8, no. 16, 2017, p. 26066, https://doi.org/10.18632/oncotarget.15257.